Skip to content
lifestyle.floredechampagne.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Parabilis Medicines, Inc.
Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis
October 14, 2026
Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
September 1, 2026
Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors
August 25, 2026
Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 20, 2026